|4Aug 22, 5:17 PM ET

Matheis Dennis 4

4 · Lucid Diagnostics Inc. · Filed Aug 22, 2025

Insider Transaction Report

Form 4
Period: 2025-08-20
Transactions
  • Purchase

    Common Stock

    2025-08-20$1.02/sh+100,000$101,840665,443 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.0085 to $1.0286. inclusive. The reporting person undertakes to provide to Lucid Diagnostics Inc., any security holder of Lucid Diagnostics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES